A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population The objective of the study is to confirm in a larger and less selected population (?real life conditions?) the positive risk-benefit balance observed with silodosin 8 mg in double-blind, randomised cl...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

NOVEL INJECTION THERAPY FOR PATIENT WITH LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA The primary objective of the core of the study is to demonstrate that a single TRUS-guided intraprostatic injection of NX-1207 provides a long lasting therapeutic improvement of LUTS associated with b...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

An international multicentre, randomized, parallel group, double-blind trial to evaluate different dose combinations of lercanidipine and enalapril in comparison with each component administered alone and with placebo in patients with essential hypertension The primary objective of this study is to evaluate the optimal dose combinations of lercanidipine and enalapril as initial treatment of patients with moderate essential hypertension.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune